Table 4.
Mean EQ‐5D scores at baseline and follow‐up with 95% confidence intervals
Subgroups | Baseline | 6 weeks | 12 weeks | 26 weeks | 52 weeks |
---|---|---|---|---|---|
SR | 0.28 (0.19–0.36) | 0.44 (0.34–0.55) | 0.55 (0.45–0.64) | 0.60 (0.49–0.71) | 0.71 (0.64–0.77) |
RA | 0.42 (0.38–0.46) | 0.51 (0.47–0.55) | 0.56 (0.52–0.64) | 0.60 (0.56–0.70) | 0.63 (0.56–0.70) |
All patients | 0.40 (0.36–0.43) | 0.50 (0.46–0.53) | 0.56 (0.52–0.60) | 0.61 (0.55–0.64) | 0.65 (0.60–0.71) |
RA, subgroup of patients treated with radiotherapy alone; SR, subgroup of patients treated with surgery and radiotherapy